Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Tivity Health Delivers Strong Results For First Quarter 2021 With 141% Year Over Year Increase In Income From Continuing Operations

      RAISING FULL YEAR GUIDANCE FOR REVENUE AND ADJUSTED EBITDA

      VIRTUAL SILVERSNEAKERS VISITS GROW 50% SEQUENTIALLY TO OVER 1.2 MILLION IN THE FIRST QUARTER

      FIRST QUARTER SILVERSNEAKERS IN-PERSON GYM VISITS GAIN MOMENTUM WITH 19% SEQUENTIAL GROWTH TO 11.2 MILLION

      NEW STREAMING CAPABILITY AND ADDITION OF NEW CIO AND CXIO DEMONSTRATE PROGRESS TOWARD BECOMING A MEMBER-CENTRIC PLATFORM ENGAGEMENT COMPANY


      News provided by

      Tivity Health, Inc.

      May 05, 2021, 16:05 ET

      Share this article

      Share this article


      NASHVILLE, Tenn., May 5, 2021 /PRNewswire/ -- Tivity Health, Inc. (NASDAQ:TVTY), today announced financial results for the first quarter ended March 31, 2021.

      Richard Ashworth, President and Chief Executive Officer, commented, "We delivered strong results for the first quarter of 2021, allowing us to tighten the ranges on revenue and Adjusted EBITDA guidance for the full year. We successfully expanded our SilverSneakers virtual offerings by launching a new Roku application for viewing on-demand content and are on track to deploy our omni-channel capabilities by the start of the third quarter.  These strategic initiatives combined with the continued momentum in the number of in-person visits give us optimism for the remainder of the year.  The recent additions of our new Chief Information Officer (CIO) and Chief Experience and Innovation Officer (CXIO) underline our commitment to quickly expand our member-centric engagement through a robust platform which includes digital and in-person experiences."

      First Quarter Highlights

      • Revenue from continuing operations was $108.1 million during the first quarter of 2021; 
      • Income from continuing operations was $19.9 million, an increase of $11.7 million, or 141%, over the prior year; 
      • Adjusted EBITDA from continuing operations was $41.2 million, representing an increase of $11.0 million, or 36%, compared to the prior year;
      • In-person SilverSneakers gym visits totaled 11.2 million for Q1 2021, growing by 19% over the fourth quarter of 2020; 
      • Virtual SilverSneakers visits accelerated, totaling 1.2 million during the quarter, a 50% increase over the fourth quarter of 2020, with 36% of virtual visit participants being new to SilverSneakers;
      • The Company ended the quarter with cash on hand of $52.4 million and a leverage ratio of 2.11, as calculated under its credit agreement.  During the first quarter of 2021, the Company prepaid $63.6 million of principal and amortization of term loan debt.  The Company's next quarterly installment is not due until December 2022;
      • A new comprehensive scientific study conducted by Avalere Health showed that total average healthcare expenses for SilverSneakers participants were 16% lower compared to non-participating Medicare Advantage members.

      First Quarter 2021 Financial Information

      Dollars in millions, except per-share data
      See pages 9-13 for a reconciliation of non-GAAP financial measures.


      Three Months Ended

      March 31,



      2021

      2020






      Revenues from Continuing Operations

      $108.1

      $159.7


      Income from Continuing Operations

      $19.9

      $8.3


      Income from Continuing Operations Margin

      18.5%

      5.2%


      Adjusted EBITDA from Continuing Operations

      $41.2

      $30.2


      Adjusted EBITDA from Continuing Operations Margin

      38.1%

      18.9%


      Diluted Earnings Per Share from Continuing Operations

      $0.40

      $0.17


      Adjusted Diluted Earnings Per Share from Continuing Operations

      $0.40

      $0.25


      Cash Flows from Operating Activities – former Healthcare segment (1)

      $22.6

      $25.7


      Free Cash Flow – former Healthcare segment (1)

      $19.4

      $22.5




      (1)

      For comparability, figures for 2020 represent cash flows from the Company's former Healthcare segment. 

      Revenues in the first quarter of 2021 of $108.1 million decreased $51.6 million, or approximately 32%, compared to the first quarter of 2020, primarily as a result of a significant decrease in SilverSneakers revenue of $41.8 million resulting from fewer revenue-generating visits due to the COVID-19 pandemic.  Additionally, Prime Fitness revenue decreased by $10.2 million primarily due to terminations and suspensions.

      The mix of SilverSneakers revenue during the first quarter of 2021 remained different from the mix during the first quarter of 2020 due to the reduction in fitness location visits resulting from the COVID-19 pandemic. Revenue from per-member-per-month fees represented 53% of the Company's SilverSneakers revenue in the first quarter of 2021, compared to 36% in the same quarter of 2020.   

      Income from continuing operations for the first quarter of 2021 was $19.9 million, an increase of $11.7 million compared to the first quarter of 2020.  Adjusted EBITDA was $41.2 million for the first quarter, or 38.1% of revenues, compared to $30.2 million for the first quarter of 2020, or 18.9% of revenues.  This improvement is primarily due to the mix of per-member-per-month fees for SilverSneakers driven by a reduction in fitness location visits and related costs for SilverSneakers and Prime, and also reflects a reduction in advertising expense and employee-related expenses.

      During the first quarter, the Company prepaid $63.6 million of principal amortization on its term loan debt, and net debt (total debt less cash and cash equivalents) improved to $353 million, resulting in a net leverage ratio of 2.11. The Company's next quarterly installment is not due until December 2022. 

      Updated 2021 Financial Guidance

      Tivity Health announced today that, based on first-quarter results and the Company's outlook for the remainder of 2021, it has updated its financial guidance as follows:

       Dollars in millions, except per-share data





      February 24, 2021

      (Prior Guidance)

      May 5, 2021

      (Updated Guidance)




      Revenues

      $455 - $485

      $465 - $485

      Income from Continuing Operations

      $70.5 - $74.3

      $71.3 - $74.3

      Adjusted EBITDA (1)

      $150 - $155

      $151 - $155

      Depreciation Expense

      Approximately $14

      Unchanged

      Interest Expense

      Approximately $37, including $6 of non-cash

      Unchanged

      Effective Tax Rate

      Approximately 25%

      Unchanged

      Weighted Average Diluted Shares Outstanding

      50.0 million – 50.5 million

      Unchanged

      Earnings per Diluted Share

      $1.40 - $1.49

      $1.41 - $1.49

      Adjusted Earnings per Diluted Share (1)

      $1.47 - $1.56

      $1.49 - $1.56

      Cash Flows from Operating Activities

      $81 - $85

      Unchanged

      Free Cash Flow (1)

      $50 - $60

      Unchanged

      Capital Expenditures

      $20 - $25

      Unchanged

      Tivity Health's detailed guidance considerations for 2021 may be found in the supplemental information posted on the Company's website at http://investors.tivityhealth.com.  

      (1)

      Adjusted EBITDA, adjusted earnings per diluted share, and free cash flow are non-GAAP financial measures. See pages 9-13 for a reconciliation of non-GAAP financial measures.   

      Conference Call

      Tivity Health will hold a conference call to discuss this release today at 5:00 p.m. Eastern Time.  Investors will have the opportunity to listen to the conference call live by dialing 877-683-2218 or 647-689-5447 for international callers, and referencing code 4896873 or over the Internet by going to www.tivityhealth.com and clicking "Investors" at least 15 minutes early to register, download, and install any necessary audio software. For those who cannot listen to the live broadcast, a telephonic replay will be available for one week at 800-585-8367 or 416-621-4642 for international callers, code 4896873, and the replay will also be available on the Company's web site for the next 7 months.

      About Tivity Health

      Tivity Health® Inc. (Nasdaq: TVTY) is a leading provider of healthy life-changing solutions, including SilverSneakers®, Prime® Fitness, WholeHealth Living® and Wisely Well™.  We are focused on becoming the modern destination for healthy living.  We will expand beyond fitness by establishing an engagement platform that enables personalized member interaction with all of our offerings, and we will partner with other payors and service providers to aggregate services to seniors under the SilverSneakers umbrella.  The continued development of our suite of digital offerings will enable a more tailored, interactive, and impactful experience across a variety of areas, including fitness, social connection, community involvement, volunteering, and enrichment.  Learn more at www.tivityhealth.com.

      Non-GAAP Financial Measures

      This press release contains certain non-GAAP financial measures. Reconciliations of certain of these non-GAAP measures to the comparable GAAP measures are included on pages 9-13.   

      Cautionary Statement Regarding Forward-Looking Statements

      This press release contains certain statements that are "forward-looking" statements within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements are based upon current expectations and include all statements that are not historical statements of fact and those regarding the intent, belief or expectations, including, without limitation, statements that are accompanied by words such as "will," "expect," "outlook," "anticipate," "intend," "plan," "believe," "seek," "see," "would," "target," or other similar words, phrases or expressions and variations or negatives of these words. These forward-looking statements include, but are not limited to, the Company's statements regarding its future financial performance. Readers of this press release should understand that these statements are not guarantees of performance or results. Many risks and uncertainties could affect actual results and cause them to vary materially from the forward-looking statements.

      These risks and uncertainties include, among other things: impacts from the COVID-19 pandemic (including the response of governmental authorities to combat and contain the pandemic, the closure of fitness centers in the Company's national network (or operational restrictions imposed on such fitness centers), reclosures and potential additional reclosures as a result of surges in positive COVID-19 cases) on the Company's business, operations or liquidity; the risks associated with changes in macroeconomic conditions (including the impacts of any recession or changes in consumer spending resulting from the COVID-19 pandemic), widespread epidemics, pandemics (such as the current COVID-19 pandemic) or other outbreaks of disease, geopolitical turmoil, and the continuing threat of domestic or international terrorism; the Company's ability to collect accounts receivable from its customers and amounts due under its sublease agreements; the market's acceptance of the Company's new products and services; the Company's ability to develop and implement effective strategies and to anticipate and respond to strategic changes, opportunities, and emerging trends in the Company's industry and/or business, as well as to accurately forecast the related impact on the Company's revenues and earnings; the impact of any impairment of the Company's goodwill, intangible assets, or other long-term assets; the Company's ability to attract, hire, or retain key personnel or other qualified employees and to control labor costs; the effectiveness of the reorganization of the Company's business and the Company's ability to realize the anticipated benefits; the Company's ability to effectively compete against other entities, whose financial, research, staff, and marketing resources may exceed its resources; the impact of legal proceedings involving the Company and/or its subsidiaries, products, or services, including any claims related to intellectual property rights, as well as our ability to maintain insurance coverage with respect to such legal proceedings and claims on terms that would be favorable to us; the impact of severe or adverse weather conditions, the current COVID-19 pandemic, and the potential emergence of additional health pandemics or infectious disease outbreaks on member participation in the Company's programs; the risks associated with deriving a significant concentration of revenues from a limited number of the Company's customers, many of whom are health plans; the Company's ability and/or the ability of its customers to enroll participants and to accurately forecast their level of enrollment and participation in the Company's programs in a manner and within the timeframe anticipated by the Company; the Company's ability to sign, renew and/or maintain contracts with its customers and/or the Company's fitness partner locations under existing terms or to restructure these contracts on terms that would not have a material negative impact on the Company's results of operations; the ability of the Company's health plan customers to maintain the number of covered lives enrolled in those health plans during the terms of the Company's agreements; the Company's ability to add and/or retain active subscribers in its Prime Fitness program; the impact of any changes in tax rates, enactment of new tax laws, revisions of tax regulations or any claims or litigation with taxing authorities; the impact of a reduction in Medicare Advantage health plan reimbursement rates or changes in plan design; the impact of any new or proposed legislation, regulations and interpretations relating to Medicare, Medicare Advantage, Medicare Supplement, and privacy and security laws; the impact of healthcare reform on the Company's business; the risks associated with potential failures of the Company's information systems or those of our third-party vendors, including as a result of telecommuting issues associated with the Company's employees working remotely, which may include a failure to execute on policies and processes in a work-from-home or remote model; the risks associated with data privacy or security breaches, computer hacking, network penetration and other illegal intrusions of the Company's information systems or those of third-party vendors or other service providers, including those risks that result from the increase in personnel working remotely, which may result in unauthorized access by third parties, loss, misappropriation, disclosure or corruption of customer, employee or the Company's information, or other data subject to privacy laws and may lead to a disruption in the Company's business, costs to modify, enhance, or remediate its cybersecurity measures, enforcement actions, fines or litigation against the Company, or damage to its business reputation; the risks associated with changes to traditional office-centered business processes and/or conducting operations out of the office in a work-from-home or remote model by us or our third party vendors during adverse situations (e.g., during a crisis, disaster, or pandemic), which may result in additional costs and/or may negatively impact productivity and cause other disruptions to the Company's business; the Company's ability to enforce its intellectual property rights; the risk that the Company's indebtedness may limit the Company's ability to adapt to changes in the economy or market conditions, expose the Company to interest rate risk for the variable rate indebtedness and require a substantial portion of cash flows from operations to be dedicated to the payment of indebtedness; the Company's ability to service its debt, make principal and interest payments as those payments become due, and remain in compliance with its debt covenants; the Company's ability to obtain adequate financing to provide the capital that may be necessary to support its current or future operations; counterparty risk associated with the Company's interest rate swap agreements; and other risks detailed in the Company's filings with the Securities and Exchange Commission.

      For additional information about factors that could cause actual results to differ materially from those described in the forward-looking statements, please refer to the Company's filings with the SEC. Except as required by law, the Company undertakes no obligation to update any such forward-looking statements to reflect new information, subsequent events or circumstances.

      TIVITY HEALTH, INC.

      CONSOLIDATED BALANCE SHEETS

      (In thousands, except share and per share data)

      (Unaudited) 






      March 31, 2021



      December 31, 2020


      Current assets:









      Cash and cash equivalents


      $

      52,428



      $

      100,385


      Accounts receivable, net



      44,959




      25,981


      Prepaid expenses



      4,154




      5,556


      Income taxes receivable



      779




      10,996


      Other current assets



      19,586




      11,336


           Total current assets



      121,906




      154,254











      Property and equipment, net of accumulated depreciation of

         $40,713 and $38,188 respectively



      19,981




      20,959


      Right-of-use assets



      16,288




      18,139


      Long-term deferred tax asset



      1,186




      3,601


      Intangible assets, net



      29,049




      29,049


      Goodwill, net



      334,680




      334,680


      Other assets



      16,808




      18,301


      Total assets


      $

      539,898



      $

      578,983











      Current liabilities:









      Accounts payable


      $

      18,400



      $

      19,741


      Accrued salaries and benefits



      5,264




      8,949


      Accrued liabilities



      31,395




      18,424


      Deferred revenue



      4,351




      4,460


      Current portion of long-term debt



      7,456




      7,456


      Current portion of lease liabilities



      8,064




      8,052


      Current portion of other long-term liabilities



      14,195




      14,753


           Total current liabilities



      89,125




      81,835











      Long-term debt



      397,750




      459,250


      Long-term lease liabilities



      9,460




      11,494


      Other long-term liabilities



      17,309




      22,748











      Commitments and contingent liabilities


















      Stockholders' equity:









      Preferred stock $.001 par value, 5,000,000 shares authorized,

         none outstanding



      —




      —


      Common Stock $.001 par value, 120,000,000 shares authorized,

         49,246,281 and 48,983,735 shares outstanding, respectively



      49




      49


      Additional paid-in capital



      513,923




      513,263


      Accumulated deficit



      (444,949)




      (464,085)


      Treasury stock, at cost, 2,254,953 shares in treasury



      (28,182)




      (28,182)


      Accumulated other comprehensive loss



      (14,587)




      (17,389)


      Total stockholders' equity



      26,254




      3,656


      Total liabilities and stockholders' equity


      $

      539,898



      $

      578,983


      TIVITY HEALTH, INC.

      CONSOLIDATED STATEMENTS OF OPERATIONS

      (In thousands, except earnings per share data)

      (Unaudited)






      Three Months Ended March 31,





      2021



      2020



      Revenues


      $

      108,085



      $

      159,692



      Cost of revenue (exclusive of depreciation of $2,531 and $1,831, respectively, included below)



      57,285




      115,148



      Marketing expense



      1,231




      7,299



      Selling, general and administrative expenses



      9,696




      12,052



      Depreciation expense



      2,683




      2,030



      Restructuring and related charges



      —




      482



      Operating income



      37,190




      22,681













      Interest expense



      10,756




      11,270



      Other (income) expense, net



      (1,130)




      —



      Total non-operating expense, net



      9,626




      11,270



      Income before income taxes



      27,564




      11,411













      Income tax expense



      7,620




      3,136



      Income from continuing operations


      $

      19,944



      $

      8,275













      Loss from discontinued operations, net of income tax benefit of $277

         and $18,282, respectively



      (808)




      (206,381)



      Net income (loss)


      $

      19,136



      $

      (198,106)













      Earnings (loss) per share - basic:










      Continuing operations


      $

      0.41



      $

      0.17



      Discontinued operations


      $

      (0.02)



      $

      (4.25)



      Net income (loss)


      $

      0.39



      $

      (4.08)













      Earnings (loss) per share - diluted:










      Continuing operations


      $

      0.40



      $

      0.17



      Discontinued operations


      $

      (0.02)



      $

      (4.22)



      Net income (loss)


      $

      0.38



      $

      (4.05)













      Comprehensive income (loss)


      $

      21,938



      $

      (217,935)













      Weighted average common shares and equivalents:










      Basic



      49,222




      48,613



      Diluted



      50,340




      48,855



      TIVITY HEALTH, INC.

      CONSOLIDATED STATEMENTS OF CASH FLOWS

      (In thousands)

      (Unaudited)




      Three Months Ended March 31,




      2021



      2020


      Cash flows from operating activities:









      Income from continuing operations


      $

      19,944



      $

      8,275


      Loss from discontinued operations



      (808)




      (206,381)


      Adjustments to reconcile net income (loss) to net cash provided by operating activities:









      Depreciation and amortization



      2,683




      14,763


      Amortization and write-off of deferred loan costs



      1,183




      1,212


      Amortization and write-off of debt discount



      1,077




      1,095


      Share-based employee compensation expense



      2,998




      824


      Gain on derivatives



      (1,130)




      —


      Impairment of goodwill and intangible assets of discontinued operation



      —




      199,500


      Deferred income taxes



      1,454




      (16,031)


      (Increase) decrease in accounts receivable, net



      (18,978)




      16,665


      Decrease in income taxes receivable



      10,217




      —


      Decrease in inventory



      —




      4,057


      Decrease in other current assets



      529




      4,746


      (Decrease) increase in accounts payable



      (42)




      12,612


      Decrease in accrued salaries and benefits



      (3,685)




      (4,852)


      Increase in other current liabilities



      5,594




      5,501


      (Decrease) increase in deferred revenue



      (109)




      3,247


      Other



      1,691




      1,790


           Net cash flows provided by operating activities


      $

      22,618



      $

      47,023











      Cash flows from investing activities:









      Acquisition of property and equipment


      $

      (1,561)



      $

      (4,875)


      Settlement on derivatives not designated as hedges



      (1,633)




      —


           Net cash flows used in investing activities


      $

      (3,194)



      $

      (4,875)











      Cash flows from financing activities:









      Proceeds from issuance of long-term debt


      $

      —



      $

      160,325


      Payments of long-term debt



      (63,600)




      (123,000)


      Payments related to tax withholding for share-based compensation



      (2,502)




      (2,795)


      Exercise of stock options



      164




      601


      Change in cash overdraft and other



      (1,443)




      3,269


           Net cash flows (used in) provided by financing activities


      $

      (67,381)



      $

      38,400











      Net (decrease) increase in cash and cash equivalents


      $

      (47,957)



      $

      80,548











      Cash and cash equivalents, beginning of period


      $

      100,385



      $

      2,486











      Cash and cash equivalents, end of period


      $

      52,428



      $

      83,034


      TIVITY HEALTH, INC. 
      RECONCILIATION OF NON-GAAP MEASURES TO GAAP MEASURES
      (Unaudited)


      Reconciliation of Income from Continuing Operations, GAAP Basis to
      Adjusted EBITDA from Continuing Operations, Non-GAAP Basis (in thousands)






      Three Months

      Ended

      March 31,

      2021



      % of
      Revenue


      Three Months
      Ended

      March 31,

      2020


      % of
      Revenue

      Income from continuing operations, GAAP basis



      $

      19,944



      18.5%

      $

      8,275


      5.2%

         Depreciation expense




      2,683





      2,030



         Interest expense




      10,756





      11,270



         Income tax expense




      7,620





      3,136



      EBITDA from continuing operations, non-GAAP basis (1)



      $

      41,003




      $

      24,711



         Acquisition, integration, project, and CEO transition costs (2)




      1,321





      5,049



         Restructuring charges (3)




      —





      482



         Other (income)/expense (4)




      (1,130)





      —



      Adjusted EBITDA from continuing operations, non-GAAP basis (5)



      $

      41,194



      38.1%

      $

      30,242


      18.9%















      (1)

      EBITDA from continuing operations is a non-GAAP financial measure.  The Company believes it is useful to investors to provide disclosures of its operating results and guidance on the same basis as that used by management.  You should not consider EBITDA from continuing operations in isolation or as a substitute for income from continuing operations determined in accordance with U.S. GAAP.

      (2)

      Acquisition, integration, project, and CEO transition costs consist of pre-tax charges of $1,321 and $5,049 for the three months ended March 31, 2021 and 2020, respectively, primarily incurred in connection with the acquisition and integration of Nutrisystem and with the termination of the Company's former CEO in February 2020 and the hiring of a new CEO in June 2020.

      (3)

      Restructuring charges consist of pre-tax charges of $482 for the three months ended March 31, 2020, primarily related to a restructuring of corporate support infrastructure and of executive leadership.

      (4)

      Other (income)/expense consists of pre-tax income of $1,130 related to certain interest rate swap agreements that do not qualify for hedge accounting treatment ("de-designated swaps") and require changes in fair value to be recognized each period in current earnings.

      (5)

      Adjusted EBITDA from continuing operations is a non-GAAP financial measure.  The Company excludes acquisition, integration, project, and CEO transition costs, restructuring charges, and other (income)/expense from this measure because of its comparability to the Company's historical operating results.  The Company updated its definition of adjusted EBITDA during the first quarter of 2021 to exclude other (income)/expense related to de-designated swaps. The Company considers such (income)/expense to be outside the performance of its ongoing core business operations and believes that presenting Adjusted EBITDA excluding other (income)/expense provides increased transparency as to the operating costs of its current business performance. The Company did not revise the prior period's Adjusted EBITDA amounts because there were no costs similar in nature to these items.  The Company believes it is useful to investors to provide disclosures of its operating results on the same basis as that used by management.  You should not consider Adjusted EBITDA from continuing operations in isolation or as a substitute for income from continuing operations determined in accordance with U.S. GAAP.  Additionally, because Adjusted EBITDA from continuing operations may be defined differently by other companies in the Company's industry, the non-GAAP financial measure presented here may not be comparable to similarly titled measures of other companies.

      Reconciliation of Income from Continuing Operations Guidance, GAAP Basis to
      Adjusted EBITDA from Continuing Operations Guidance, Non-GAAP Basis (in millions)






      Year

      Ending

      December 31,

      2021



      Income from continuing operations guidance, GAAP basis




      $71.3 - $74.3



         Depreciation expense




      14



         Interest expense




      37



         Income tax expense




      23.8 – 24.8



      EBITDA from continuing operations, non-GAAP basis (6)




      $146 - $150



         Integration, project, and CEO transition costs (7)




      5



      Adjusted EBITDA from continuing operations guidance, non-GAAP basis (8)




      $151 - $155










      (6)

      EBITDA from continuing operations guidance is a non-GAAP financial measure.  The Company believes it is useful to investors to provide disclosures of its operating results and guidance on the same basis as that used by management.  You should not consider EBITDA from continuing operations guidance in isolation or as a substitute for income from continuing operations determined in accordance with U.S. GAAP.  Figures may not add due to rounding.

      (7)

      Integration, project, and CEO transition costs primarily relate to strategic projects and the Company's transition to a new CEO during 2020.

      (8)

      Adjusted EBITDA from continuing operations guidance is a non-GAAP financial measure.  The Company excludes integration, project, and CEO transition costs from this measure because of its comparability to the Company's historical operating results.  The Company believes it is useful to investors to provide disclosures of its operating results and guidance on the same basis as that used by management.  You should not consider Adjusted EBITDA from continuing operations guidance in isolation or as a substitute for income from continuing operations guidance determined in accordance with U.S. GAAP.  Additionally, because Adjusted EBITDA from continuing operations guidance may be defined differently by other companies in the Company's industry, the non-GAAP financial measure presented here may not be comparable to similarly titled measures of other companies.

      Reconciliation of Net Cash Flows Provided by Operations, GAAP Basis to
      Free Cash Flow, Non-GAAP Basis (in thousands)






      Three Months

      Ended

      March 31,

      2021




      Three Months

      Ended

      March 31,

      2020


      Net cash flows provided by operations, GAAP basis



      $

      22,618



      $

      47,023


         Acquisition of property and equipment




      (1,561)




      (4,875)


       Settlement on derivatives not designated as hedges




      (1,633)




      —


      Free cash flow, non-GAAP basis (9)



      $

      19,424



      $

      42,148












      (9)

      Free cash flow is a non-GAAP financial measure and is defined by the Company as net cash flows provided by operating activities less acquisition of property and equipment and settlement on derivatives not designated as hedges.  The Company updated its definition of free cash flow during the fourth quarter of 2020 to exclude settlement on derivatives not designated as hedges. The Company considers these costs to be a reduction of cash available for other uses and believes that presenting free cash flow excluding settlement on derivatives provides increased transparency. The Company did not revise prior periods' free cash flow because there were no costs similar in nature to this item. The Company believes free cash flow is a useful measure of performance and an indication of the strength of the Company and its ability to generate cash.  The Company believes it is useful to investors to provide disclosures of its results on the same basis as that used by management.  You should not consider free cash flow in isolation or as a substitute for net cash flows provided by operating activities determined in accordance with U.S. GAAP. Additionally, because free cash flow may be defined differently by other companies in the Company's industry, the non-GAAP financial measure presented here may not be comparable to similarly titled measures of other companies.

      Reconciliation of Net Cash Flows Provided by Operations from Former Healthcare Segment, GAAP Basis
      to Free Cash Flow from Former Healthcare Segment, Non-GAAP Basis (in thousands)






      Three Months

      Ended

      March 31,

      2021




      Three Months

      Ended

      March 31,

      2020


      Net cash flows provided by operations from former Healthcare segment, GAAP basis



      $

      22,618



      $

      25,735


         Acquisition of property and equipment




      (1,561)




      (3,193)


         Settlement on derivatives not designated as hedges




      (1,633)




      —


      Free cash flow from former Healthcare segment, non-GAAP basis (10)



      $

      19,424



      $

      22,542












      (10)

      Free cash flow from former Healthcare segment is a non-GAAP financial measure and is defined by the Company as net cash flows provided by operating activities less acquisition of property and equipment and settlement on derivatives not designated as hedges.  The Company updated its definition of free cash flow during the fourth quarter of 2020 to exclude settlement on derivatives not designated as hedges. The Company considers these costs to be a reduction of cash available for other uses and believes that presenting free cash flow excluding settlement on derivatives provides increased transparency. The Company did not revise prior periods' free cash flow because there were no costs similar in nature to this item. The Company believes free cash flow is a useful measure of performance and an indication of the strength of the Company and its ability to generate cash.  The Company believes it is useful to investors to provide disclosures of its results on the same basis as that used by management.  You should not consider free cash flow from former Healthcare segment in isolation or as a substitute for net cash flows provided by operating activities determined in accordance with U.S. GAAP. Additionally, because free cash flow may be defined differently by other companies in the Company's industry, the non-GAAP financial measure presented here may not be comparable to similarly titled measures of other companies.

      Reconciliation of Net Cash Flows Provided by Operations Guidance, GAAP Basis to
      Free Cash Flow Guidance, Non-GAAP Basis (in millions)






      Year Ending

      December 31,

      2021



      Net cash flows provided by operations guidance, GAAP basis



      $

      81 - 85



         Acquisition of property and equipment guidance




      (25 - 20)



         Settlement on derivatives not designated as hedges guidance




      (6 - 5)



      Free cash flow guidance, non-GAAP basis (11)



      $

      50 - 60










      (11)

      Free cash flow guidance is a non-GAAP financial measure and is defined by the Company as net cash flows provided by operating activities less acquisition of property and equipment and settlement on derivatives not designated as hedges.  The Company believes free cash flow is a useful measure of performance and an indication of the strength of the Company and its ability to generate cash.  The Company believes it is useful to investors to provide disclosures of its results and guidance on the same basis as that used by management.  You should not consider free cash flow guidance in isolation or as a substitute for net cash flows provided by operating activities guidance determined in accordance with U.S. GAAP. Additionally, because free cash flow may be defined differently by other companies in the Company's industry, the non-GAAP financial measure presented here may not be comparable to similarly titled measures of other companies.

      Reconciliation of Earnings Per Share ("EPS") from Continuing Operations, GAAP Basis to
      Adjusted EPS from Continuing Operations, Non-GAAP Basis (footnote amounts in thousands)





      Three Months

      Ended

      March 31,

      2021



      Three Months

      Ended

      March 31,

      2020



      EPS from continuing operations, GAAP basis


      $

      0.40


      $

      0.17



         Net loss per share attributable to acquisition, integration, project, CEO transition, and restructuring costs (12)



      0.02



      0.08



         Net income per share attributable to other (income)/expense (13)



      (0.02)



      —



      Adjusted EPS from continuing operations, non-GAAP basis (14)


      $

      0.40


      $

      0.25












      (12)

      Net loss attributable to acquisition, integration, project, CEO transition, and restructuring costs consists of pre-tax charges of $1,321 and $5,531 for the three months ended March 31, 2021 and 2020, respectively.  These costs primarily related to the acquisition and integration of Nutrisystem, the termination of our former CEO in February 2020 and hiring of our new CEO in June 2020, and restructuring activities as described in Note 3 above.  The tax rate applied to these charges was 25%, which represented the combined estimated U.S. federal and state statutory tax rate.

      (13)

      Net income attributable to other (income)/expense consists of pre-tax income of $1,130 for the three months ended March 31, 2021 related to de-designated swaps, as described in Note 4 above.  The tax rate applied to this income was 25%, which represented the combined estimated U.S. federal and state statutory tax rate

      (14)

      Adjusted EPS from continuing operations is a non-GAAP financial measure.  The Company excludes net (income) loss per share attributable to acquisition, integration, CEO transition, and restructuring costs and other (income)/expense from this measure because of its comparability to the Company's historical operating results.  The Company believes it is useful to investors to provide disclosures of its operating results on the same basis as that used by management.  You should not consider adjusted EPS from continuing operations in isolation or as a substitute for EPS from continuing operations determined in accordance with U.S. GAAP.  Additionally, because adjusted EPS from continuing operations may be defined differently by other companies in the Company's industry, the non-GAAP financial measures presented here may not be comparable to similarly titled measures of other companies.

      Reconciliation of EPS from Continuing Operations Guidance, GAAP Basis to Adjusted EPS from
      Continuing Operations Guidance, Non-GAAP Basis (footnote amounts in thousands)





      Year

      Ending

      December 31,
      2021



      EPS from continuing operations guidance, GAAP basis



      $1.41 - $1.49



         Net loss per share attributable to restructuring, integration project, and CEO transition costs guidance (15)



      0.07



      Adjusted EPS from continuing operations guidance, non-GAAP basis (16)


      $

      $1.49 – 1.56









      (15)

      Net loss per share attributable to restructuring, integration, project, and CEO transition costs guidance consists of pre-tax charges of $5,000 for the year ending December 31, 2021.  These costs primarily relate to strategic projects, the Company's transition to a new CEO during 2020, and restructuring activities.  The tax rate applied to these charges was 25%, which represents the combined estimated U.S. federal and state statutory tax rate.

      (16)

      Adjusted EPS from continuing operations guidance is a non-GAAP financial measure.  The Company excludes net loss attributable to restructuring, project, and CEO transition costs from this measure because of its comparability to the Company's historical operating results.  The Company believes it is useful to investors to provide disclosures of its operating results and guidance on the same basis as that used by management.  You should not consider adjusted EPS from continuing operations guidance in isolation or as a substitute for EPS from continuing operations guidance determined in accordance with U.S. GAAP.  Additionally, because adjusted EPS from continuing operations guidance may be defined differently by other companies in the Company's industry, the non-GAAP financial measures presented here may not be comparable to similarly titled measures of other companies.  Figures may not add due to rounding.

      Reconciliation of Total Debt, GAAP Basis
      to Net Debt, Non-GAAP Basis (in thousands)






      March 31,

      2021




      March 31,

      2020


      Total debt, GAAP basis



      $

      405,206



      $

      1,087,599


       Cash and cash equivalents




      (52,428)




      (83,034)


      Net debt, non-GAAP basis (17)



      $

      352,778



      $

      1,004,565












      (17)

      Net debt is a non-GAAP financial measure.  The Company excludes cash and cash equivalents from this measure and believes that net debt is an important measure to monitor its leverage and evaluate the balance sheet.  The Company believes it is useful to investors to provide disclosures of its financial position on the same basis as that used by management.  You should not consider net debt in isolation or as a substitute for total debt determined in accordance with U.S. GAAP.  Additionally, because net debt may be defined differently by other companies in the Company's industry, the non-GAAP financial measures presented here may not be comparable to similarly titled measures of other companies.

      SOURCE Tivity Health, Inc.

      Modal title

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.